Domperidone BP 5 mg


1. Prevention and symptomatic relief of acute nausea and vomiting in adults from any cause including cytotoxic therapy, radiotherapy and antiparkinsonism therapy. 2. Stimulation of gut motility a) Non-ulcer dyspepsia b) Esophageal reflux, reflux esophagitis and gastritis c) Diabetic gastroparesis d) Funcitonal dyspepsia e) Speeding barium transit in 'follow-throught' radiological studies 3. Relieves nausea associated with migraine attack. Children: Use in children is restricted to nausea and vomiting following cytotoxics or radiotherapy.


Adults: 10-20 mg (1-2 tablets or 10-20 ml suspension 3 to 4 times daily, before meal. Children: Nausea and vomiting following cytotoxic therapy or radiotherapy only; 200-400 µgm/kg (2-4 ml suspension / 10 kg or 0.4-0.8 ml drop / 10 kg) body weight 3 to 4 times daily (Doridon should be taken 15-30 minutes before meal. Maximum period of treatment is 12 weeks.)